FAM66C and cholangiocarcinoma: FAM66C is not much reported compared to the above lncRNAs, but it is illustrated to promote cell proliferation by suppressing proteasome pathway in prostate cancer, promote cancer progression in cholangiocarcinoma and pancreatic cancer (63–65).